Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial
Abstract Background The anti-inflammatory properties of cannabinoids have been shown. This study was conducted to assess effect of oleoylethanolamide (OEA) supplementation on glycemic status, insulin resistance (IR) and inflammatory factor in pre-diabetic individuals. Methods This double-blind rando...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-06-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-022-00848-3 |
| _version_ | 1828821202100027392 |
|---|---|
| author | Elahe Pouryousefi Maryam Javadi Sima Hashemipour Mohamadreza Rashidi Nooshabadi Hossein Khadem Haghighian |
| author_facet | Elahe Pouryousefi Maryam Javadi Sima Hashemipour Mohamadreza Rashidi Nooshabadi Hossein Khadem Haghighian |
| author_sort | Elahe Pouryousefi |
| collection | DOAJ |
| description | Abstract Background The anti-inflammatory properties of cannabinoids have been shown. This study was conducted to assess effect of oleoylethanolamide (OEA) supplementation on glycemic status, insulin resistance (IR) and inflammatory factor in pre-diabetic individuals. Methods This double-blind randomized clinical trial was done at Qazvin University of Medical Sciences in which 46 pre-diabetic patients were divided into two equal groups and received one 125 mg OEA capsule in the intervention group (23 subjects) and 125 mg capsule containing wheat flour in placebo group daily for 8 weeks. After collecting demographic information, at the beginning and end of the study, the questionnaires of physical activity, 24-hour food recall were completed and blood glucose (BG), plasma insulin level, IR, hemoglobin A1c (HbA1c), and C-reactive protein (CRP) were measured. Statistical analysis was performed using SPSS software. Results At the beginning and end of the study, there was no significant difference between the two groups in terms of anthropometric indices, food intake and physical activity (P > 0.05). At the end of the study, consumption of OEA significantly reduced BS, insulin, IR, HbA1c, and CRP (P < 0.05). No significant change was observed in mentioned biochemical factors in placebo group (P > 0.05). Conclusions Given that OEA supplementation improved the glycemic status, IR and reduced the inflammatory factor, use of this supplement can be introduced as a useful supplement to control pre-diabetes status. Trial registration: The protocol of this clinical trial is registered with the Iranian Registry of Clinical Trials ( http://www.IRCT.IR , identifier: IRCT20141025019669N16). |
| first_indexed | 2024-12-12T12:49:48Z |
| format | Article |
| id | doaj.art-c6c515314fd148c288641dd09ea0aac9 |
| institution | Directory Open Access Journal |
| issn | 1758-5996 |
| language | English |
| last_indexed | 2024-12-12T12:49:48Z |
| publishDate | 2022-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Diabetology & Metabolic Syndrome |
| spelling | doaj.art-c6c515314fd148c288641dd09ea0aac92022-12-22T00:24:01ZengBMCDiabetology & Metabolic Syndrome1758-59962022-06-011411910.1186/s13098-022-00848-3Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trialElahe Pouryousefi0Maryam Javadi1Sima Hashemipour2Mohamadreza Rashidi Nooshabadi3Hossein Khadem Haghighian4Department of Nutrition, School of Health, Qazvin University of Medical SciencesChildren Growth Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical SciencesMetabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical SciencesDepartment of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical SciencesDepartment of Nutrition, School of Health, Qazvin University of Medical SciencesAbstract Background The anti-inflammatory properties of cannabinoids have been shown. This study was conducted to assess effect of oleoylethanolamide (OEA) supplementation on glycemic status, insulin resistance (IR) and inflammatory factor in pre-diabetic individuals. Methods This double-blind randomized clinical trial was done at Qazvin University of Medical Sciences in which 46 pre-diabetic patients were divided into two equal groups and received one 125 mg OEA capsule in the intervention group (23 subjects) and 125 mg capsule containing wheat flour in placebo group daily for 8 weeks. After collecting demographic information, at the beginning and end of the study, the questionnaires of physical activity, 24-hour food recall were completed and blood glucose (BG), plasma insulin level, IR, hemoglobin A1c (HbA1c), and C-reactive protein (CRP) were measured. Statistical analysis was performed using SPSS software. Results At the beginning and end of the study, there was no significant difference between the two groups in terms of anthropometric indices, food intake and physical activity (P > 0.05). At the end of the study, consumption of OEA significantly reduced BS, insulin, IR, HbA1c, and CRP (P < 0.05). No significant change was observed in mentioned biochemical factors in placebo group (P > 0.05). Conclusions Given that OEA supplementation improved the glycemic status, IR and reduced the inflammatory factor, use of this supplement can be introduced as a useful supplement to control pre-diabetes status. Trial registration: The protocol of this clinical trial is registered with the Iranian Registry of Clinical Trials ( http://www.IRCT.IR , identifier: IRCT20141025019669N16).https://doi.org/10.1186/s13098-022-00848-3OleoylethanolamideGlycemic statusInsulin resistancePrediabetes |
| spellingShingle | Elahe Pouryousefi Maryam Javadi Sima Hashemipour Mohamadreza Rashidi Nooshabadi Hossein Khadem Haghighian Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial Diabetology & Metabolic Syndrome Oleoylethanolamide Glycemic status Insulin resistance Prediabetes |
| title | Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial |
| title_full | Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial |
| title_fullStr | Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial |
| title_full_unstemmed | Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial |
| title_short | Improved glycemic status, insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes: a randomized controlled trial |
| title_sort | improved glycemic status insulin resistance and inflammation after receiving oral oleoylethanolamide supplement in people with prediabetes a randomized controlled trial |
| topic | Oleoylethanolamide Glycemic status Insulin resistance Prediabetes |
| url | https://doi.org/10.1186/s13098-022-00848-3 |
| work_keys_str_mv | AT elahepouryousefi improvedglycemicstatusinsulinresistanceandinflammationafterreceivingoraloleoylethanolamidesupplementinpeoplewithprediabetesarandomizedcontrolledtrial AT maryamjavadi improvedglycemicstatusinsulinresistanceandinflammationafterreceivingoraloleoylethanolamidesupplementinpeoplewithprediabetesarandomizedcontrolledtrial AT simahashemipour improvedglycemicstatusinsulinresistanceandinflammationafterreceivingoraloleoylethanolamidesupplementinpeoplewithprediabetesarandomizedcontrolledtrial AT mohamadrezarashidinooshabadi improvedglycemicstatusinsulinresistanceandinflammationafterreceivingoraloleoylethanolamidesupplementinpeoplewithprediabetesarandomizedcontrolledtrial AT hosseinkhademhaghighian improvedglycemicstatusinsulinresistanceandinflammationafterreceivingoraloleoylethanolamidesupplementinpeoplewithprediabetesarandomizedcontrolledtrial |